Study Tests Office-Based Transperineal Approach to Prostate Biopsies
(MedPage Today) -- A multicenter randomized trial compared transperineal prostate biopsy without antibiotic prophylaxis versus transrectal biopsy with targeted prophylaxis, examining infections, prostate cancer detection, pain, and other measures... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 29, 2024 Category: Hematology Source Type: news
Report: Second type of prostate cancer identified by AI
New research by two British universities has identified a new aggressive form of prostate cancer using artificial intelligence, which could change the way the disease is found and treated. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 29, 2024 Category: Consumer Health News Source Type: news
GE HealthCare features new ultrasound, MRI offerings at ECR 2024
VIENNA – GE HealthCare (GEHC) is highlighting a revamped ultrasound product line, the European launch of its Signa Champion 1.5-tesla MRI scanner, and its Care Pathways program in its exhibit area at ECR 2024.
In ultrasound, GEHC is debuting Logiq Totus, a midrange, full-body scanner designed for use in a variety of clinical scenarios. Totus includes technology that was previously only available on its higher-end systems, such as its cSound architecture, according to the vendor.
Totus features AI-powered voice control as well as decision support via Breast and Thyroid Assistant software from GEHC partner Koios. It’s ...
Source: AuntMinnie.com Headlines - February 29, 2024 Category: Radiology Authors: Erik L. Ridley Tags: Clinical News Ultrasound Source Type: news
Prostate cancer is NOT just one disease: Huge breakthrough as scientists discover illness is actually split into two types - and it could save thousands of lives
The team, led by researchers at the University of Oxford and the University of Manchester, used AI to study DNA changes in prostate cancer samples. (Source: the Mail online | Health)
Source: the Mail online | Health - February 29, 2024 Category: Consumer Health News Source Type: news
Study offers hope in identifying high-risk prostate cancer patients
Researchers find way to classify prostate cancer that might help identify 15% of men with more aggressive typeThe most common type of prostate cancer has two distinct ways of developing in the body, researchers have found, opening up new possibilities for identifying which patients need treatment.Prostate cancer is the most common form of cancer in men, withone in eight diagnosed with the disease during their lifetime. Most prostate cancersare adenocarcinomas– a type of cancer that forms in the glandular tissue that lines certain internal organs. But while the disease can kill, for many patients the risk is low.Continue ...
Source: Guardian Unlimited Science - February 29, 2024 Category: Science Authors: Nicola Davis Science correspondent Tags: Prostate cancer Society Cancer research Science Medical research UK news Health Men Source Type: news
Radiologists and AI-powered health informatics: Leading the way in screening
Sham Sokka, chief operating and technology officer of DeepHealth, discusses why he is excited about this year’s ECR congress in Vienna.
What are you most excited about for ECR this year?
Vienna is such a beautiful city and I’m so excited to be here at The European Congress of Radiology (ECR 2024) again this year.
At DeepHealth, this represents an exciting time – to showcase our pioneering offering, present new data, and meet and network with experts in the field of screening and radiology. I always relish the opportunity to talk to our customers from around the world.
Everything we do at DeepHealth is about empow...
Source: AuntMinnie.com Headlines - February 29, 2024 Category: Radiology Authors: DeepHealth Tags: Artificial Intelligence Source Type: news
Janux Stock Launches 230% On Its'Significant Opportunity' In Prostate Cancer Treatment
(Source: Reuters: Health)
Source: Reuters: Health - February 28, 2024 Category: Consumer Health News Source Type: news
Janux Stock Launches 180% On Its'Significant Opportunity' In Prostate Cancer Treatment
Janux Therapeutics unveiled promising results for a prostate cancer treatment on Tuesday, and the biotech stock nearly tripled. The post Janux Stock Launches 180% On Its 'Significant Opportunity' In Prostate Cancer Treatment appeared first on Investor's Business Daily.#januxtherapeutics #januxstocklaunches (Source: Reuters: Health)
Source: Reuters: Health - February 27, 2024 Category: Consumer Health News Source Type: news
Risk of fractures and falls in men with advanced or metastatic prostate cancer receiving androgen deprivation therapy and treated with novel androgen receptor signalling inhibitors: a systematic review and meta-analysis of randomised controlled trials - Jones C, Gray S, Brown M, Brown J, McCloskey E, Rai BP, Clarke N, Sachdeva A.
CONTEXT: The addition of androgen receptor signalling inhibitors (ARSIs) to standard androgen deprivation therapy (ADT) has improved survival outcomes in patients with advanced prostate cancer (PCa). Advanced PCa patients have a higher incidence of osteopo... (Source: SafetyLit)
Source: SafetyLit - February 26, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
A&E doctor shares six signs of prostate cancer as 'diagnoses are increasing'
If you spot any of these signs you should speak to your GP. (Source: Daily Express - Health)
Source: Daily Express - Health - February 24, 2024 Category: Consumer Health News Source Type: news
Cancer incidence during pandemic lower than expected
Overall cancer incidence in the U.S. was significantly lower than expected during the first 10 months of the COVID-19 pandemic, according to research published February 22 in JAMA Oncology.
A team led by Krystle Lang Kuhs, PhD, from the University of Kentucky in Lexington found that cancer incidence from March to December 2020 included 134,395 potentially undiagnosed cancer cases, lower than expected.
“These findings identify a substantial deficit of diagnosed cancer cases in the U.S. during the COVID-19 pandemic in 2020, which underscores the need to reengage individuals in recommended cancer screenings and routine he...
Source: AuntMinnie.com Headlines - February 22, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties CT Breast Imaging Source Type: news
Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPC
(MedPage Today) -- In patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease progressed on a novel hormonal therapy, the combination of cabozantinib (Cabometyx) plus atezolizumab (Tecentriq) improved radiographic progression... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 22, 2024 Category: Hematology Source Type: news
Perceived vs Actual Cognitive Impairment in Prostate Cancer Perceived vs Actual Cognitive Impairment in Prostate Cancer
Following hormone therapy, patients with prostate cancer may perceive an increase in cognitive issues, despite tests showing no objective decline, a recent meta-analysis found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 22, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Is MRI Screening Unnecessarily High in Prostate Cancer? Is MRI Screening Unnecessarily High in Prostate Cancer?
New research suggests that review of current prostate cancer screening guidelines may be needed, as MRI frequently fails to detect cancer-indicative lesions, even in men with elevated PSA levels.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 21, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Nigeria: Prostate Cancer - Medicaid Cancer Foundation Partners Raise Awareness Using Art
[Daily Trust] Medicaid Cancer Foundation (MCF) and partners have said art plays a critical role in the fight against prostate and other types of cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 21, 2024 Category: African Health Tags: Health and Medicine Nigeria West Africa Source Type: news
